Top Stock Picks for May 30: Aurobindo Pharma, Gokaldas Exports. Top shares have been recommended by various stock market experts to buy on May 30. These stocks will provide you with profit, according to experts. Because of the tariffs imposed by Donald Trump, the value of stocks had a major change. According to Bajaj Broking Research, Aurobindo Pharma and Gokaldas Exports are the top stock picks for today, May 30, 2025. To know more about the topic “Top Stock Picks for May 30: Aurobindo Pharma, Gokaldas Exports,” read the complete article.
Top Stock Picks for May 30: Aurobindo Pharma, Gokaldas Exports
Benchmark indexes continued consolidation for the second week in a row with stock-specific action. Nifty is seen settling in the range of 24,400-25,200. The Indian equity market maintains a strong upward bias in spite of a number of global macroeconomic and geopolitical challenges, such as increased geopolitical tensions, ongoing uncertainty surrounding global trade tariffs, and high U.S. bond yields. The benchmark Nifty 50 index has maintained its positive trend and is now placed around the 24,800 level. From a short-term technical perspective, the market attitude remains constructive.
The Bank Nifty index has also been settling within a wide range of 53,500 to 56,000 over the prior five weeks. A major finding from the daily chart showed that the index has recovered only 38.2% of its earlier nine-session rally, indicating underlying strength. Analysts anticipate that the Bank Nifty will continue its consolidation phase, with a breakout above 56,000 signaling a potential upward movement towards 56,700. Investors are advised to view dips within this range as buying opportunities, particularly with key support identified at 54,000 to 53,500, which aligns with the lower boundary of the recent trading range and key moving averages.
Bajaj Broking has selected Aurobindo Pharma as a solid buy within the price range of Rs 1,155 to Rs 1,175. The stock is currently recovering from a rising trendline, suggesting buying interest at lower levels. Analysts expect it to reach a target of Rs 1,278 over the next three months, resulting in a possible return of 10%. Similarly, Gokaldas Exports is suggested for purchase in the range of Rs 960 to rs 980, with a target price of Rs 1090, which translates to a 12% return over the same period. The stock is demonstrating signs of strength, trading above significant averages and experiencing buying demand from prior breakout levels.
Aurobindo Pharma Limited
Aurobindo Pharma Limited is an India-based pharmaceutical company. The company is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, branded pharmaceuticals, generic pharmaceuticals and related services. It product portfolio is spread over seven therapeutic/product areas encompassing Central nervous system (CNS), Antiretrovirals (ARVs), Cardiovascular (CVS), SSP- Orals & Sterile, Anti-infectives, anti-diabetics, and cephalosporins – Orals. It is engaged in developing a range of oncology and hormonal products.
Stocks: Buy in the range of Rs 1155-1175.
The stock is rebounding, taking support at the rising trendline support joining lows of the last 3 months, signaling buying demand at lower levels. The daily stochastic is rebounding from the oversold territory and has generated a buy signal, moving above its three-period average, thus validating positive bias. We expect the stock to head towards 1278 levels in the coming months, being the 80% retracement of the previous decline (1356-1010) and the high of April 2025.
Gokaldas Exports Limited
Gokaldas Exports Limited (GEX) is engaged in the business of design, manufacture, and sale of a wide range of garments for men, women, and children and caters to the needs of several international fashion brands and retailers. The Company deals in a broad range of apparel products that include outerwear, activewear, and fashion wear for all weather and seasons. GEX has a strong global footprint, with operations in India, Kenya, and Ethiopia and marketing functions in the UAE and USA. It caters to clients across Europe, US, and other prominent markets, leveraging its diversified capabilities.
Stocks: Buy in the range of Rs 960-980
The stock is witnessing buying demand from the previous major breakout area and the confluence of 20- & 50-day EMAs signaling strength and offering a fresh entry opportunity. It is currently trading above the short- and long-term moving averages signaling strength and overall positive bias.
The daily stochastic is rebounding from the oversold territory and has generated a buy signal, moving above its three-period average, thus validating positive bias. We expect the stock to head towards 1090 levels in the coming months, being the 80% retracement of the previous decline (1060-925).
